Biotechnology Market Research Reports & Industry Analysis

Biotechnology is a rapidly evolving industry that holds immense potential for growth and innovation across a wide range of product applications and markets. At MarketResearch.com, we offer a variety of biotechnology market research reports that provide valuable insights and data on key market segments across the world.

Biotech Market Research to Fuel Business Growth

Our reports answer critical questions about the biotechnology market to help guide your business strategies. Our research covers:

  • Current market performance, industry outlooks, and industry lifecycles
  • Expert analysis of supply chains, products and services, market drivers and challenges, and major markets to watch
  • Market share information, profiles of established and emerging players, discussion of key success factors, and financial benchmarking
  • Insights into new technologies and patents, pipeline analysis, data on revenue fluctuations, and overviews of regulations & policies

Stay Ahead with our Biotechnology Industry Analysis

The biotechnology market is advancing at a fast pace, with new technologies and products emerging all the time. Our reports help businesses stay up to date on these changes and identify new opportunities for growth. With our trusted reputation and commitment to quality, MarketResearch.com is the ideal source for biotechnology market research reports written by experienced analysts with extensive knowledge of the industry. MarketResearch.com has been a trusted source for business intelligence for over 20 years, and our long-time clients include many leading companies in the life sciences. If you need assistance, our team of knowledgeable research specialists are always available to help expedite the process.

...Show More ...Show Less


Biotechnology Industry Research & Market Reports

  • Next Generation Cancer Diagnostics

    ... reach US$64.6 Billion by 2030, growing at a CAGR of 21.4% over the analysis period 2023-2030. qPCR & Multiplexing Technology, one of the segments analyzed in the report, is expected to record a 22.4% CAGR ... Read More

  • Nutrigenomics

    ... of 16.1% over the analysis period 2023-2030. Nutrigenomics Reagents & Kits, one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$2.0 Billion by the end of the ... Read More

  • Personalized Nutrition

    ... at a CAGR of 13.5% over the analysis period 2023-2030. Active Measurement, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$27.5 Billion by the end of ... Read More

  • Plant Genomics

    ... at a CAGR of 7.8% over the analysis period 2023-2030. Molecular Engineering, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$10.5 Billion by the end of ... Read More

  • Degenerative Disc Disease Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

    ... market size was valued at USD 26.05 billion in 2021, and the market is now projected to grow from USD 27.87 billion in 2022 to USD 45.92 billion by 2029, exhibiting a CAGR of 7.4% ... Read More

  • Biotech Financial Reports November 2024

    BIOTECH FINANCIAL REPORTS provides the latest financial information and news on biotech and pharmaceutical companies. This includes quarterly and annual reports plus merger and acquisition news, and stock dividend announcements. Read More

  • Worldwide Biotech November 2024

    ... an international industry, reporting on the deals between U.S. biotechnology companies and international pharmaceutical corporations. Monitors the emerging European Community marketplace and the growing Japanese interest and deals in the U.S. biotechnology and pharmaceuticals industry. Read More

  • Scaffold Technology

    ... at a CAGR of 7.0% over the analysis period 2023-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the ... Read More

  • Microbiome Sequencing Services

    ... by 2030, growing at a CAGR of 18.1% over the analysis period 2023-2030. Synthesis Technique, one of the segments analyzed in the report, is expected to record a 16.8% CAGR and reach US$2.3 Billion by ... Read More

  • Microbial Fermentation Technology

    ... by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Antibiotics Application, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$16.2 Billion by ... Read More

  • Nanoemulsions

    ... of 7.8% over the analysis period 2023-2030. Topical Administration, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$4.2 Billion by the end of the analysis period. ... Read More

  • Artificial Intelligence (AI) in Drug Discovery

    ... the year 2023, is expected to reach US$13.5 Billion by 2030, growing at a CAGR of 26.4% over the analysis period 2023-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected ... Read More

  • Stem Cell Manufacturing

    ... by 2030, growing at a CAGR of 7.9% over the analysis period 2023-2030. Culture Media, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$9.2 Billion by ... Read More

  • Stem Cell Therapy

    ... by 2030, growing at a CAGR of 16.4% over the analysis period 2023-2030. Allogeneic Stem Cell Therapy, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$1.0 ... Read More

  • GMO Crops and Seeds

    ... reach US$102.0 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Corn Crop, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach ... Read More

  • Precision Medicine Software

    ... by 2030, growing at a CAGR of 10.0% over the analysis period 2023-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$2.6 Billion by ... Read More

  • Precision Medicine

    ... at a CAGR of 8.7% over the analysis period 2023-2030. Diagnostics Application, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$89.0 Billion by the end of ... Read More

  • Protein Detection and Quantification

    ... reach US$3.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and ... Read More

  • Protein Extracts from Single Cell Protein and Other Conventional Sources

    ... Single Cell Protein and Other Conventional Sources estimated at US$27.9 Billion in the year 2023, is expected to reach US$44.0 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Plant ... Read More

  • Enzymes

    ... of 6.0% over the analysis period 2023-2030. Microorganisms Source, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$17.9 Billion by the end of the analysis period. ... Read More

  • Short-Read Sequencing

    ... at a CAGR of 9.9% over the analysis period 2023-2030. Next-Generation Sequencing Technology, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$25.0 Billion by the end ... Read More

  • Molecular Biology Enzymes and Kits & Reagents

    ... US$28.5 Billion in the year 2023, is expected to reach US$70.5 Billion by 2030, growing at a CAGR of 13.8% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the ... Read More

  • Biological Drugs

    ... at a CAGR of 9.1% over the analysis period 2023-2030. Therapeutic Protein, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$289.1 Billion by the end of ... Read More

  • Biologics

    ... of 8.2% over the analysis period 2023-2030. Recombinant Therapeutic Proteins, one of the segments analyzed in the report, is expected to record a 8.8% CAGR and reach US$271.3 Billion by the end of the analysis ... Read More

  • Biotech Flavors

    ... at a CAGR of 6.8% over the analysis period 2023-2030. Vanilla & Vanillin Flavor, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$872.9 Million by the ... Read More

Cookie Settings